AssetMark Inc’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.9K | Hold |
3,445
| – | – | ﹤0.01% | 1698 |
|
|
2025
Q1 | $25.8K | Hold |
3,445
| – | – | ﹤0.01% | 1634 |
|
|
2024
Q4 | $25.9K | Hold |
3,445
| – | – | ﹤0.01% | 1595 |
|
|
2024
Q3 | $26.2K | Hold |
3,445
| – | – | ﹤0.01% | 1439 |
|
|
2024
Q2 | $21.3K | Hold |
3,445
| – | – | ﹤0.01% | 1379 |
|
|
2024
Q1 | $17.5K | Buy |
3,445
+1,495
| +77% | +$7.6K | ﹤0.01% | 1300 |
|
|
2023
Q4 | $11.7K | Hold |
1,950
| – | – | ﹤0.01% | 1361 |
|
|
2023
Q3 | $13.8K | Hold |
1,950
| – | – | ﹤0.01% | 1289 |
|
|
2023
Q2 | $13.7K | Hold |
1,950
| – | – | ﹤0.01% | 1258 |
|
|
2023
Q1 | $16.3K | Buy |
1,950
+450
| +30% | +$3.75K | ﹤0.01% | 1222 |
|
|
2022
Q4 | $17.2K | Buy |
1,500
+470
| +46% | +$5.4K | ﹤0.01% | 1230 |
|
|
2022
Q3 | $13K | Buy |
+1,030
| New | +$13K | ﹤0.01% | 1193 |
|
|
2022
Q1 | – | Sell |
-96
| Closed | -$1K | – | 1547 |
|
|
2021
Q4 | $1K | Buy |
+96
| New | +$1K | ﹤0.01% | 1412 |
|